The technology is used to create an implant designed for each patient’s individual anatomy based on a three-dimensional CT scan of the patient’s knee. The trial will enroll patients who need unicompartmental knee implants due to osteoarthritis. Participants will be followed for 10 years after the procedure to determine the effectiveness of the personalized implant.
Read the report on ConforMIS.
Read Articles Related to ConforMIS:
ConforMIS Receives FDA Approval for iTotal Patient-Specific Total Knee Replacement System
10 Points on Personalized Knee Replacements
ConforMIS Releases Second Generation Knee Resurfacing System
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
